Literature DB >> 3707634

Necrotizing systemic vasculitis with features of both Wegener's granulomatosis and Churg-Strauss vasculitis.

S Henochowicz, D Eggensperger, L Pierce, W F Barth.   

Abstract

We describe a patient who had nasal biopsy-demonstrated eosinophilic vasculitis and renal biopsy-demonstrated necrotizing glomerulonephritis with tissue eosinophilia. Despite corticosteroid therapy, the patient's renal function deteriorated, and nodular pulmonary infiltrates developed. Both conditions responded dramatically when cyclophosphamide was added to the treatment regimen. The renal disease activity was monitored with the aid of cytodiagnostic urinalysis, a technique of limited, albeit well-established, validity in monitoring renal allograft patients for signs of tissue rejection. This technique provided an improved, semi-quantitative method for examining urine sediment and, in this patient, was helpful as a measure of renal disease activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707634     DOI: 10.1002/art.1780290417

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

Review 1.  The necrotising vasculitides.

Authors:  E H Sawicka
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

2.  Crescentic glomerulonephritis and eosinophilic interstitial infiltrates in a patient with hypereosinophilic syndrome.

Authors:  P Richardson; G Dickinson; S Nash; L Hoffman; R Steingart; M Germain
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

3.  An eosinophilic variant granulomatosis with polyangiitis involving the dura, bilateral orbits, and mastoids.

Authors:  Hasan Al-Hakami; Abdurhman S Al-Arfaj; Mohammed Al-Sohaibani; Najma A Khalil
Journal:  Saudi Med J       Date:  2016-06       Impact factor: 1.484

Review 4.  A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

Authors:  Michele V Quan; Stephen K Frankel; Mehrnaz Maleki-Fischbach; Laren D Tan
Journal:  BMC Pulm Med       Date:  2018-11-29       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.